Samsara BioCapital’s Centessa Pharmaceuticals CNTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-1,693,736
| Closed | -$6.52M | – | 49 |
|
|
2023
Q1 | $6.52M | Hold |
1,693,736
| – | – | 1.35% | 16 |
|
|
2022
Q4 | $5.25M | Hold |
1,693,736
| – | – | 1.13% | 19 |
|
|
2022
Q3 | $6.81M | Hold |
1,693,736
| – | – | 1.59% | 17 |
|
|
2022
Q2 | $8.25M | Sell |
1,693,736
-190,360
| -10% | -$927K | 2.2% | 15 |
|
|
2022
Q1 | $16.9M | Buy |
1,884,096
+424,403
| +29% | +$3.81M | 4.25% | 6 |
|
|
2021
Q4 | $16.4M | Sell |
1,459,693
-77,840
| -5% | -$876K | 3.19% | 9 |
|
|
2021
Q3 | $25.7M | Hold |
1,537,533
| – | – | 4.03% | 7 |
|
|
2021
Q2 | $34.1M | Buy |
+1,537,533
| New | +$34.1M | 4.22% | 6 |
|